All News #Library
Others
Minghui Pharmaceutical Announces $131 Million Pre-IPO Financing
07 Aug 2025 //
CONTRACTPHARMA
Minghui Pharma Announces Phase I Results of MHB039A for Tumors
06 Nov 2024 //
PR NEWSWIRE
China-based biotech plans ph. 3 after seeing midstage eye data
22 Oct 2024 //
FIERCE BIOTECH
Minghui Announces First Patient Enrollment in Phase 3 Clinical Study of MH004
17 Aug 2023 //
PR NEWSWIRE
Minghui doses first healthy volunteer in trial of TED therapy
24 May 2023 //
CLINICAL TRIALS ARENA
Minghui Pharma Announces Phase 2 Clinical Trial Success of MH004 Cream
14 Apr 2023 //
PR NEWSWIRE

Market Place
Sourcing Support